211 related articles for article (PubMed ID: 21656657)
1. Should we use living donor grafts for patients with hepatocellular carcinoma? Ethical considerations.
Pomfret EA; Lodge JP; Villamil FG; Siegler M
Liver Transpl; 2011 Oct; 17 Suppl 2():S128-32. PubMed ID: 21656657
[No Abstract] [Full Text] [Related]
2. Should we perform deceased donor liver transplantation after living donor liver transplantation has failed?
Greig PD; Geier A; D'Alessandro AM; Campbell M; Wright L
Liver Transpl; 2011 Oct; 17 Suppl 2():S139-46. PubMed ID: 21563294
[No Abstract] [Full Text] [Related]
3. Should the liver transplant criteria for hepatocellular carcinoma be different for deceased donation and living donation?
Grant D; Fisher RA; Abecassis M; McCaughan G; Wright L; Fan ST
Liver Transpl; 2011 Oct; 17 Suppl 2():S133-8. PubMed ID: 21634006
[No Abstract] [Full Text] [Related]
4. Living-donor grafts for patients with hepatocellular carcinoma.
Akoad ME
Virtual Mentor; 2012 Mar; 14(3):215-20. PubMed ID: 23352007
[No Abstract] [Full Text] [Related]
5. Living donor liver transplantation for hepatocellular carcinoma: current status in Korea.
Lee SG; Moon DB; Shin H; Kim KH; Ahn CS; Ha TY; Song GW; Jung DH; Park GC
Transplant Proc; 2012 Mar; 44(2):520-2. PubMed ID: 22410060
[No Abstract] [Full Text] [Related]
6. Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantation.
Kneteman N; Livraghi T; Madoff D; de Santibañez E; Kew M
Liver Transpl; 2011 Oct; 17 Suppl 2():S117-27. PubMed ID: 21584926
[No Abstract] [Full Text] [Related]
7. Selection criteria for patients with hepatocellular carcinoma in liver transplantation.
Kaido T; Takada Y; Uemoto S
Transplantation; 2009 Aug; 88(3):442-3; author reply 443. PubMed ID: 19667951
[No Abstract] [Full Text] [Related]
8. Treatment of recurrent hepatocellular carcinoma after liver transplantation.
Davis E; Wiesner R; Valdecasas J; Kita Y; Rossi M; Schwartz M
Liver Transpl; 2011 Oct; 17 Suppl 2():S162-6. PubMed ID: 21688382
[No Abstract] [Full Text] [Related]
9. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience.
Mazzaferro V; Bhoori S; Sposito C; Bongini M; Langer M; Miceli R; Mariani L
Liver Transpl; 2011 Oct; 17 Suppl 2():S44-57. PubMed ID: 21695773
[No Abstract] [Full Text] [Related]
10. Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma.
Samuel D; Colombo M; El-Serag H; Sobesky R; Heaton N
Liver Transpl; 2011 Oct; 17 Suppl 2():S6-13. PubMed ID: 21858912
[TBL] [Abstract][Full Text] [Related]
11. Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: a review and consensus statement.
Prasad KR; Young RS; Burra P; Zheng SS; Mazzaferro V; Moon DB; Freeman RB
Liver Transpl; 2011 Oct; 17 Suppl 2():S81-9. PubMed ID: 21748847
[No Abstract] [Full Text] [Related]
12. What is the role of adjuvant therapy after liver transplantation for hepatocellular carcinoma?
Duvoux C; Kiuchi T; Pestalozzi B; Busuttil R; Miksad R
Liver Transpl; 2011 Oct; 17 Suppl 2(Suppl 2):S147-58. PubMed ID: 21714065
[No Abstract] [Full Text] [Related]
13. Which matters most: number of tumors, size of the largest tumor, or total tumor volume?
Germani G; Gurusamy K; Garcovich M; Toso C; Fede G; Hemming A; Suh KS; Weber A; Burroughs AK
Liver Transpl; 2011 Oct; 17 Suppl 2():S58-66. PubMed ID: 21584928
[No Abstract] [Full Text] [Related]
14. Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma?
Yao FY; Breitenstein S; Broelsch CE; Dufour JF; Sherman M
Liver Transpl; 2011 Oct; 17 Suppl 2():S109-16. PubMed ID: 21584927
[No Abstract] [Full Text] [Related]
15. Who decides? Living donor liver transplantation for advanced hepatocellular carcinoma.
Volk ML; Marrero JA; Lok AS; Ubel PA
Transplantation; 2006 Nov; 82(9):1136-9. PubMed ID: 17102762
[TBL] [Abstract][Full Text] [Related]
16. Living donor liver transplantation in patients who have received pretransplant treatment for hepatocellular carcinoma.
Yoshizumi T; Shirabe K; Soejima Y; Taketomi A; Ikegami T; Uchiyama H; Harada N; Ijichi H; Maehara Y
Transplantation; 2011 Apr; 91(8):e61-2. PubMed ID: 21475066
[No Abstract] [Full Text] [Related]
17. Immunosuppression and hepatocellular carcinoma.
Schlitt HJ; Mornex F; Shaked A; Trotter JF
Liver Transpl; 2011 Oct; 17 Suppl 2():S159-61. PubMed ID: 21506251
[No Abstract] [Full Text] [Related]
18. Prognostic significance of preoperative imaging in recipients of living donor liver transplantation for hepatocellular carcinoma.
Sugimachi K; Shirabe K; Taketomi A; Soejima Y; Iguchi T; Takeishi K; Toshima T; Aishima S; Tajima T; Maehara Y
Transplantation; 2011 Mar; 91(5):570-4. PubMed ID: 21343876
[TBL] [Abstract][Full Text] [Related]
19. Living donor liver transplantation.
White SA; Pollard SG
Br J Surg; 2005 Mar; 92(3):262-3. PubMed ID: 15739247
[No Abstract] [Full Text] [Related]
20. Should we expand the criteria for hepatocellular carcinoma with living-donor liver transplantation?--no, never.
Hiatt JR; Carmody IC; Busuttil RW
J Hepatol; 2005 Oct; 43(4):573-7. PubMed ID: 16112768
[No Abstract] [Full Text] [Related]
[Next] [New Search]
